Psilocybin Therapy May Ease Severe PTSD - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Psilocybin Therapy May Ease Severe PTSD

Open‐label pilot trial found substantial symptom improvement and favorable safety findings in veterans receiving psilocybin-based therapy, supporting larger controlled studies.

  • By

  • Andrea Surnit

  • July 31, 2026

  • 3 min

Share

  • 1

    Psilocybin-assisted therapy may be safe and show early clinical efficacy in military veterans with severe PTSD.

  • 2

    Twelve veterans completed an 11-week intervention, including preparatory psychotherapy and two psilocybin dosing sessions.

  • 3

    Seventy-five percent of participants achieved a treatment response, and 83% experienced clinically meaningful symptom improvement.

  • 4

    No serious adverse events were reported, with mild to moderate transient effects like headache and anxiety observed.

  • 5

    The study's small sample size and open-label design limit generalizability, necessitating larger randomized controlled trials.

Original Source(s)

Psilocybin Therapy May Ease Severe PTSD

  • by Andrea Surnit

  • July 31, 2026

Related Content

Can SGLT2 Inhibitors Affect Dementia?

A target trial emulation using Veterans Affairs electronic health records examined neuropsychiatric outcomes associated with SGLT2 inhibitor use.

Impact of a virtual reality program on the cognitive and psycho-emotional state of seniors with mild cognitive impairment

Anxiety symptoms following conception through assisted reproductive technology: a systematic review